Cached score snapshot

US.ROP · Roper Technologies

110分制 67/110;5D動能v2 17/50;排序分 84/160

Ranking score 84/160
Main score 67/110
5D momentum v2 17/50
Rank #31
Setup grade D 38.2

Score breakdown

謹慎買入

Medium twelvedata

Score and price trend

D 38.2 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 08-04 09-16 10-28 11-18 12-08 $322.44$412.80$503.16 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling calibration best · score 2.507 · anchors 120 -1.13% -2.83% / +2.05% 45% 10% Actual outcome pending · 0 / 3 bars observed
30D observation -1.09% -14.97% / +5.53% 45% 45% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 -0.10% -3.54% / +2.62% 49.4% 17.5% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-08-04 → 2026-12-08 · 120 archived points · 2 Improving turn signal · 7 Deteriorating signal · 3 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 84
Display grade 謹慎買入
Model version cursor_18_27_news_v2_160
Main score 67/110 (謹慎買入)
5D momentum v2 17/50 (弱)
Score with momentum v2 84/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 384.111
ma50 389.4396
close 434.48
prevClose 441.65
avgVolume20 854563
volumeRatio 1.37
changePercent -1.62

Metrics snapshot

close 434.48
volume 1169556
changePercent -1.62

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 67/110
Main rating 謹慎買入
5D momentum v2 17/50
Score with momentum v2 84/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 4.6/5 · 優秀

Dimension score 4.6/5
Dimension grade 優秀

Sub-items

pbPoints 0.5
pePoints 0.5
epsPoints 0
roePoints 0.4
debtPoints 0.5
marginPoints 0.75
turnoverUsdM 508.1487
volumePoints 0.5
revenuePoints 0.6
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 13.2/20 · 一般

Dimension score 13.2/20
Dimension grade 一般

Sub-items

cmfPoints 2.4
mfiPoints 0.8
obvPoints 4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.ROP
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 7.4/15 · 較差

Dimension score 7.4/15
Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred
vixClose 18.39

trend

score 1.8

details

qqq

ma20 733.184
ma50 725.2622
name QQQ
close 721.24
points 0.4

spy

ma20 770.4115
ma50 767.5288
name SPY
close 769.66
points 1.4
source twelvedata+fred
atrPct 2.7519
atrPoints 3
cciPoints 0.8
vixPoints 1.8
marketTrendPoints 1.8

催化劑 — 10/20 · 較差

Dimension score 10/20
Dimension grade 較差

Sub-items

catalyst

score 10

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 2
catalystPoints 10

風險管理 — 6.8/10 · 一般

Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.7519
turnoverUsdM 508.1487
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.ROP
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 410.5672

strength_details

ma_score 1
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.5
take_profit_price 460.9834
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 6.1
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Information Technology
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.5038
diversificationPoints 2

技術信號 — 17/30 · 較差

Dimension score 17/30
Dimension grade 較差

Sub-items

bbPoints 3
adxPoints 3
sarPoints 2.4
vcpPoints 0.9
macdPoints 4

vcpPayload

vcp_pass false
vcp_score 0.9
vcp_reason 站上MA50;升放量(近10日3日);Ready=N;Confirm=N

vcp_metrics

up_days 8
vol_ref 915730
down_days 1
vcp_ready false
above_ma50 true
avg_vol_10 966590
avg_vol_20 826545
avg_vol_30 915730
range_pct_10 0.1936
range_pct_20 0.2378
range_pct_30 0.2378
up_expand_ok true
lookback_used 59
near_20d_high true
contraction_ok false
down_shrink_ok false
up_expand_days 3
breakout_20d_ok false
vol_ratio_10_30 1.0555
dist_to_20d_high 0.0361
down_shrink_days 1
breakout_level_20d 450.76
vcp_breakout_confirm false
contraction_ratio_10_30 0.8142
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction false
kdjAdxPoints 0.5
rsiKdjPoints 0.8
volumeWeight 2
maCrossPoints 0
shortRsiPoints 0.8
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 8/10 · 優秀

Dimension score 8/10
Dimension grade 優秀

Sub-items

sentiment

score 8

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 6
sentimentScoreRaw 1.8

sentimentData

raw {"id":143234657,"url":"https://finnhub.io/api/news?id=abb42726f9194b1f9f2d877aae1d467b8dcc4fd922276c49e688d2c56c93e5bf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies reported third quarter 2026 sales of US$2,171.8 million and net income of US$484.7 million, with GAAP diluted EPS from continuing operations of US$4.88. The company also issued fourth quarter GAAP DEPS guidance of US$4.27 to US$4.32, plus full year guidance of US$25.60 to US$25.65. The nine month numbers, including US$6,376 million in sales and US$2,162.1 million in net income, highlight how Roper Technologies’ software heavy portfolio is currently converting revenue into...","category":"company","datetime":1793106727,"headline":"Did Earnings Beat Just Shift Roper Technologies (ROP) Investment Narrative?"}, {"id":143234658,"url":"https://finnhub.io/api/news?id=675afc98361468a388b4330cef5f25647af91cbe677acd3cb0ab3112ae4b5e8a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) is back in focus after releasing third quarter results showing higher sales, earnings and per share profits, alongside fresh guidance for the fourth quarter and full year 2026. That earnings beat has coincided with a sharp shift in sentiment, with a 7 day share price return of 15.16% and a 30 day gain of 23.17% pushing Roper Technologies to US$441.65, even though the 1 year total shareholder return is still down 3.84%. Scan how Roper Technologies compares with other...","category":"company","datetime":1793102907,"headline":"Roper Technologies (ROP), What Is Behind The Fresh Attention?"}, {"id":143166055,"url":"https://finnhub.io/api/news?id=e62f46f508d0e89dd36db60a4043b87d3ac6d3ded9befe7c05a37d3780ebd303","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding has delivered a strong multi year share price run, helped by a busy drug pipeline and fresh clinical data. This raises a simple question for you as an investor: Is the current price still aligned with what the business is earning today? Roche Holding has returned 82.3% over the past 3 years, so a lot of optimism about its earnings power is already reflected in the recent share price story. Recent Phase III results in kidney disease and neuroimmunology, plus new collaborations...","category":"company","datetime":1792858454,"headline":"Can Roche Holding (SWX:ROP) Still Be Cheap After Fresh Trial Wins?"}, {"id":143104800,"url":"https://finnhub.io/api/news?id=eda56412a9bf8d111997cd779adb0d407aebce2dee25e1bb764c3fb6eabb95fb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies has rallied sharply in recent weeks, which puts the focus squarely on whether the current share price lines up with what its cash flows can justify. For anyone following the stock, the question now is whether that move is supported by the cash the business is expected to generate over time. The share price has risen 19.9% over the past month, which puts more pressure on the underlying cash flow story to support where Roper Technologies now trades. The company focuses on...","category":"company","datetime":1792710836,"headline":"Roper (ROP) Stock May Be 16% Undervalued On Cash Flow"}, {"id":143103823,"url":"https://finnhub.io/api/news?id=cc16cb08ed07a3a289e24d2ec61d1809b17b4f4833e9552bed971180b3eb57f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Software momentum drove 7% organic growth as management raised full-year guidance.","category":"company","datetime":1792692924,"headline":"Roper (ROP) Q3 2026 Earnings Call Transcript"}, {"id":143102762,"url":"https://finnhub.io/api/news?id=35d58b3c4add634369f4b436981903e24a70bf74d8b124c91a90d11a48f3b417","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper beats Q3 earnings estimates as 7% organic revenue growth fueled all three segments, while higher 2026 earnings guidance signals continued growth.","category":"company","datetime":1792680600,"headline":"ROP Q3 Earnings Beat Estimates on Solid Organic Growth"}, {"id":143100654,"url":"https://finnhub.io/api/news?id=21cf17c3e8c277fa4d7ebee36e513c17ab551274b4c01f76f786328ea2ad8142","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Although the revenue and EPS for Roper Technologies (ROP) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.","category":"company","datetime":1792672204,"headline":"Roper Technologies (ROP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates"}, {"id":143099600,"url":"https://finnhub.io/api/news?id=c44273d4b70d1a497a094cfc237b2a1dc4ed7eb3492d21a490236ed01e8fb1ec","image":"https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp","source":"ChartMill","related":"ROP","summary":"Roper Q3 2026 results met estimates; FY adjusted EPS guidance raised. Shares slipped premarket after a strong run. Read key earnings takeaways.","category":"company","datetime":1792672067,"headline":"Roper Technologies (NASDAQ:ROP) Q3 2026: In-Line Results and Raised EPS Guidance Meet a Muted Market Reaction"}
raw_source {"id":143234657,"url":"https://finnhub.io/api/news?id=abb42726f9194b1f9f2d877aae1d467b8dcc4fd922276c49e688d2c56c93e5bf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies reported third quarter 2026 sales of US$2,171.8 million and net income of US$484.7 million, with GAAP diluted EPS from continuing operations of US$4.88. The company also issued fourth quarter GAAP DEPS guidance of US$4.27 to US$4.32, plus full year guidance of US$25.60 to US$25.65. The nine month numbers, including US$6,376 million in sales and US$2,162.1 million in net income, highlight how Roper Technologies’ software heavy portfolio is currently converting revenue into...","category":"company","datetime":1793106727,"headline":"Did Earnings Beat Just Shift Roper Technologies (ROP) Investment Narrative?"}, {"id":143234658,"url":"https://finnhub.io/api/news?id=675afc98361468a388b4330cef5f25647af91cbe677acd3cb0ab3112ae4b5e8a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) is back in focus after releasing third quarter results showing higher sales, earnings and per share profits, alongside fresh guidance for the fourth quarter and full year 2026. That earnings beat has coincided with a sharp shift in sentiment, with a 7 day share price return of 15.16% and a 30 day gain of 23.17% pushing Roper Technologies to US$441.65, even though the 1 year total shareholder return is still down 3.84%. Scan how Roper Technologies compares with other...","category":"company","datetime":1793102907,"headline":"Roper Technologies (ROP), What Is Behind The Fresh Attention?"}, {"id":143204260,"url":"https://finnhub.io/api/news?id=efbec167be6227a085c19a10ed44b0ab4847c5760aeaef1c3380049b1046d021","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"With $6 billion in deployment capacity and mid-90s software retention, Roper has both the firepower and the moat to compound shareholder returns through disciplined M&A.","category":"company","datetime":1793050476,"headline":"Roper Technologies: 3 Key Takeaways for Long-Term Investors"}, {"id":143204022,"url":"https://finnhub.io/api/news?id=7481a76e11433e997e2e804e967bcd278caa6ec86f97abe592f7aa9008e58984","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Intel's manufacturing recovery and AI expansion, Novartis' growth drugs and Itau Unibanco's strategic moves headline today's top analyst reports.","category":"company","datetime":1793043180,"headline":"Top Analyst Reports for Intel, Novartis & Itau Unibanco"}, {"id":143233934,"url":"https://finnhub.io/api/news?id=b0e5a997f0730047eb65d04bacb237ab99689c804859e402ea219b707ee38366","image":"https://cdn.benzinga.com/files/images/story/2026/10/26/Roper-Technologies--Inc--Logo.jpg?width=2048&height=1536","source":"Benzinga","related":"ROP","summary":"JPMorgan upgraded Roper to Neutral rating and raised its target citing organic growth, earnings and software M&A outlook.","category":"company","datetime":1793018686,"headline":"Roper Technologies Analyst Turns Bullish After Q3 Print"}, {"id":143233935,"url":"https://finnhub.io/api/news?id=605bf03079b3ed06887c1eb633ff58dd475fb7e13a17077dc6c69a2d94d096bf","image":"","source":"Benzinga","related":"ROP","summary":"JP Morgan analyst Chigusa Katoku upgrades Roper Technologies (NASDAQ:ROP) from Underweight to Neutral and raises the price target from $415 to $490.","category":"company","datetime":1793016624,"headline":"JP Morgan Upgrades Roper Technologies to Neutral, Raises Price Target to $490"}, {"id":143195146,"url":"https://finnhub.io/api/news?id=645be5240719f0bfb8637e24ad7ff89962905300a709d133cc8f9a73ef89949a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Pre-Market Stock Futures: Futures are trading higher as we head into a new week that will finish out October, with traders trying to rally stocks after last week’s losing effort. With Halloween on Saturday, this week may be as scary as last week. All major indices closed lower again on Friday after a midday attempt […]","category":"company","datetime":1793015203,"headline":"Here Are Monday’s Top Wall Street Analyst Research Calls: Block, Boise Cascade, Equifax, FirstEnergy, Lockheed Martin, Lumentum Holdings, NetApp, Roper Technologies, Spotify, Technology, and More"}, {"id":143166055,"url":"https://finnhub.io/api/news?id=e62f46f508d0e89dd36db60a4043b87d3ac6d3ded9befe7c05a37d3780ebd303","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding has delivered a strong multi year share price run, helped by a busy drug pipeline and fresh clinical data. This raises a simple question for you as an investor: Is the current price still aligned with what the business is earning today? Roche Holding has returned 82.3% over the past 3 years, so a lot of optimism about its earnings power is already reflected in the recent share price story. Recent Phase III results in kidney disease and neuroimmunology, plus new collaborations...","category":"company","datetime":1792858454,"headline":"Can Roche Holding (SWX:ROP) Still Be Cheap After Fresh Trial Wins?"}, {"id":143162853,"url":"https://finnhub.io/api/news?id=2db318dc4a25c97d1a7494bbdf5136a328c2c69f069372f18733503ae2f3c653","image":"https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/219ce2e9e505d26ba97bb843a7c37b56.png?io=w640","source":"SeekingAlpha","related":"ROP","summary":"Wall Street weekly recap: hotter CPI, rising VIX, tech weakness and big bank earnings.","category":"company","datetime":1792829457,"headline":"Wall Street Breakfast: What Moved Markets This Week"}, {"id":143164433,"url":"https://finnhub.io/api/news?id=24a8559c9542550e9f8063b8dadafb8e401f1dd7ebcd7a371148f268f1f49bce","image":"","source":"Benzinga","related":"ROP","summary":"Jefferies analyst Brent Thill maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $500 to $540.","category":"company","datetime":1792774081,"headline":"Jefferies Maintains Buy on Roper Technologies, Raises Price Target to $540"}, {"id":143164434,"url":"https://finnhub.io/api/news?id=dc798839962a0a60e4c18126dd268e89a314d806990674924bb29ea58a6c3c5d","image":"","source":"Benzinga","related":"ROP","summary":"Citigroup analyst George Kurosawa maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $450 to $525.","category":"company","datetime":1792766409,"headline":"Citigroup Maintains Buy on Roper Technologies, Raises Price Target to $525"}, {"id":143164435,"url":"https://finnhub.io/api/news?id=922aedbb64662747cb082dcca41d5363551297bf558e52fcc7507692df045fb7","image":"","source":"Benzinga","related":"ROP","summary":"Truist Securities analyst Terry Tillman maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $475 to $500.","category":"company","datetime":1792763607,"headline":"Truist Securities Maintains Buy on Roper Technologies, Raises Price Target to $500"}, {"id":143164436,"url":"https://finnhub.io/api/news?id=5f609b495a88ead61dae1912eeb3bafbc6cc6dc92d5359e9931dd4e20aba04c4","image":"","source":"Benzinga","related":"ROP","summary":"RBC Capital analyst Rishi Jaluria maintains Roper Technologies (NASDAQ:ROP) with a Sector Perform and raises the price target from $417 to $450.","category":"company","datetime":1792751177,"headline":"RBC Capital Maintains Sector Perform on Roper Technologies, Raises Price Target to $450"}, {"id":143104800,"url":"https://finnhub.io/api/news?id=eda56412a9bf8d111997cd779adb0d407aebce2dee25e1bb764c3fb6eabb95fb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies has rallied sharply in recent weeks, which puts the focus squarely on whether the current share price lines up with what its cash flows can justify. For anyone following the stock, the question now is whether that move is supported by the cash the business is expected to generate over time. The share price has risen 19.9% over the past month, which puts more pressure on the underlying cash flow story to support where Roper Technologies now trades. The company focuses on...","category":"company","datetime":1792710836,"headline":"Roper (ROP) Stock May Be 16% Undervalued On Cash Flow"}, {"id":143104279,"url":"https://finnhub.io/api/news?id=b413e4c8b517e8cfdfb1eb9b6ad2fc45d05f0aae5401f53f574ba0fc6f9671c9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Adjusted earnings rose 15% to $5.89 a share, beating expectations.","category":"company","datetime":1792700640,"headline":"Roper Stock Surges on Earnings Beat. Investors See Promise in Its AI Push."}, {"id":143103966,"url":"https://finnhub.io/api/news?id=391c657cf8b8bd35500edd8dd058ed723150150e5d1af02abfbbe21633204915","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ROP","summary":"Roper Technologies, Allegion and Lennar led S&P 500 gainers on Oct. 22, 2026, while Moderna, Coherent and Lumentum were among the biggest decliners.","category":"company","datetime":1792695971,"headline":"S&P 500 Top Movers: Gainers and Losers for Oct. 22, 2026"}, {"id":143103823,"url":"https://finnhub.io/api/news?id=cc16cb08ed07a3a289e24d2ec61d1809b17b4f4833e9552bed971180b3eb57f4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Software momentum drove 7% organic growth as management raised full-year guidance.","category":"company","datetime":1792692924,"headline":"Roper (ROP) Q3 2026 Earnings Call Transcript"}, {"id":143103377,"url":"https://finnhub.io/api/news?id=c8afb9bea0bf2ab175008c85cd0d14e631a9cdd56fe6f0e655f0cd26a08d43f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Key TakeawaysRoper Technologies shares jumped 9. 2% today after third-quarter adjusted EPS of $5.","category":"company","datetime":1792689481,"headline":"Roper Technologies Soars 9.2% on Earnings Beat and Guidance Raise: “Exceeded Our Expectations”"}, {"id":143103378,"url":"https://finnhub.io/api/news?id=e821dc4a6040d0f8414b092b42533f102884622ae912a2fb5f8cc5af82f77d51","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Moby summary of Roper Technologies, Inc.'s Q3 2026 earnings call","category":"company","datetime":1792688441,"headline":"Roper Technologies, Inc. Q3 2026 Earnings Call Summary"}, {"id":143103959,"url":"https://finnhub.io/api/news?id=51f992e7d1a0d25e891ecf23d9ee9e29de2639e286d463e8e3dcaab8e7305397","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"ROP","summary":"S&P 500 top movers for today's session, led by ALLE, ROP, LEN, NDAQ and BX among gainers, while COHR, LRCX, FLEX, VST and CIEN ranked among losers.","category":"company","datetime":1792686972,"headline":"S&P 500 Top Movers: Gainers and Losers in Today's Session"}, {"id":143102761,"url":"https://finnhub.io/api/news?id=13f7ed0b26f1e396c0f9e1912d458db1ab30c3cc43b7b2c2ad1288f5b3e796b3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (NASDAQ:ROP) reported third-quarter 2026 results marked by 7% organic revenue growth, 15% adjusted diluted earnings-per-share growth and continued investment in artificial intelligence products and bolt-on acquisitions. Revenue rose 8% year over year to $2.2 billion, while EBITDA","category":"company","datetime":1792681503,"headline":"Roper Technologies Q3 Earnings Call Highlights"}, {"id":143102762,"url":"https://finnhub.io/api/news?id=35d58b3c4add634369f4b436981903e24a70bf74d8b124c91a90d11a48f3b417","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper beats Q3 earnings estimates as 7% organic revenue growth fueled all three segments, while higher 2026 earnings guidance signals continued growth.","category":"company","datetime":1792680600,"headline":"ROP Q3 Earnings Beat Estimates on Solid Organic Growth"}, {"id":143103957,"url":"https://finnhub.io/api/news?id=b64b1675fefb4698e90c91b13a3bd84b8afa72c0ad07e0b0aa287e90b8342fea","image":"https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp","source":"ChartMill","related":"ROP","summary":"S&P 500 gap movers in today's session include ALLE, LMT, CSX, PG and ROP among gap-up leaders, while COHR, FLEX, GEV, LRCX and TER were among gap-down laggards.","category":"company","datetime":1792679747,"headline":"S&P 500 Gap-Up and Gap-Down Movers in Today's Session"}, {"id":143133146,"url":"https://finnhub.io/api/news?id=2ed675c0f68b6a82b354a501d37a0d3af1af388703cb3284c683b79d0b8610cf","image":"https://cdn.benzinga.com/files/images/story/2026/10/22/Menlo-Park--Ca--Usa--June-7--2026-Meta-H.jpg?width=2048&height=1536","source":"Benzinga","related":"ROP","summary":"Meta's higher AI spending plan drags tech lower as Treasurys rally and the 10-year yield drops below 5%. Gold, silver and Bitcoin fall; oil climbs.","category":"company","datetime":1792675597,"headline":"Meta Tumbles 6% on AI Spending Fears, 10-Year Yield Falls Below 5%: Stock Market Today"}, {"id":143100654,"url":"https://finnhub.io/api/news?id=21cf17c3e8c277fa4d7ebee36e513c17ab551274b4c01f76f786328ea2ad8142","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Although the revenue and EPS for Roper Technologies (ROP) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.","category":"company","datetime":1792672204,"headline":"Roper Technologies (ROP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates"}, {"id":143099600,"url":"https://finnhub.io/api/news?id=c44273d4b70d1a497a094cfc237b2a1dc4ed7eb3492d21a490236ed01e8fb1ec","image":"https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp","source":"ChartMill","related":"ROP","summary":"Roper Q3 2026 results met estimates; FY adjusted EPS guidance raised. Shares slipped premarket after a strong run. Read key earnings takeaways.","category":"company","datetime":1792672067,"headline":"Roper Technologies (NASDAQ:ROP) Q3 2026: In-Line Results and Raised EPS Guidance Meet a Muted Market Reaction"}, {"id":143100655,"url":"https://finnhub.io/api/news?id=5089936d9b7b38d8a913211444750305caab80995d7a2cb37bf8d8af171fd77d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) delivered earnings and revenue surprises of +1.73% and -0.26%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1792667702,"headline":"Roper Technologies (ROP) Q3 Earnings Beat Estimates"}, {"id":143098876,"url":"https://finnhub.io/api/news?id=e6fe629a3c93cefb10cc6c6abdd98585f298047eeb679649d7eb990b4ec6a9e6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"(ROP) on Thursday reported third-quarter profit of $484.On a per-share basis, the Sarasota, Florida-based company said it had net income of $4.","category":"company","datetime":1792667091,"headline":"Roper Technologies: Q3 Earnings Snapshot"}, {"id":143097805,"url":"https://finnhub.io/api/news?id=2e924393526fcc39fb48f5d7855f01ebb11c3294d9d7ac872e727d7352b93a13","image":"https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp","source":"ChartMill","related":"ROP","summary":"Roper Technologies fits Caviar Cruise quality screens on growth, EBIT and cash profit, but weak liquidity and low standard ROIC warrant caution.","category":"company","datetime":1792666838,"headline":"Roper Technologies (NASDAQ:ROP): A Quality Investing Candidate With Strong Margins and Balance-Sheet Watch Items"}, {"id":143098877,"url":"https://finnhub.io/api/news?id=890d1d9e4cc621903c1ee2615832056f3a692e9ca11e0e521e9a5a5130d26e24","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Increases full year DEPS guidanceSARASOTA, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the third quarter ended September 30, 2026. Third quarter 2026 highlights Revenue increased 8% to $2.17 billion; organic revenue was +7% and acquisition contribution was +1%GAAP net earnings increased 22% to $485 million; adjusted net earnings increased 5% to $586 millionAdjusted EBITDA increased 7% to $864 millionGAAP DEPS increased 33% to $4.8","category":"company","datetime":1792666500,"headline":"Roper Technologies Announces Third Quarter Financial Results"}, {"id":143101575,"url":"https://finnhub.io/api/news?id=5f6da5854dad153badbeaf5d051173e4a0e26ceb42976da8803128c37d28d9b9","image":"https://cdn.benzinga.com/files/images/story/2026/10/22/Stock-market-chart-with-green-candlestic.jpg?width=2048&height=1536","source":"Benzinga","related":"ROP","summary":"Roper Techs (NASDAQ:ROP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time access to earnings","category":"company","datetime":1792660028,"headline":"Roper Techs Q3 2026 Earnings Call Transcript"}, {"id":143101576,"url":"https://finnhub.io/api/news?id=84f8df6cfe48b7d0593108cae431fb0482df7df9079a89bcb2707b20e1a6437a","image":"","source":"Benzinga","related":"ROP","summary":"Roper Technologies (NASDAQ:ROP) is looking for Q4 Adj EPS of $5.95-$6.00 vs $5.91 analyst estimate..","category":"company","datetime":1792652257,"headline":"Roper Technologies Sees Q4 Adj EPS $5.95-$6.00 vs $5.91 Est"}, {"id":143101577,"url":"https://finnhub.io/api/news?id=9bc943c9314cae8d74c2dd9caee385bf4e0174c28bd6b51c85b4414bce10267f","image":"","source":"Benzinga","related":"ROP","summary":"Roper Technologies (NASDAQ:ROP) raises FY2026 Adj EPS guidance from $22.15-$22.30 to $22.35-$22.40 vs $22.22 analyst estimate..","category":"company","datetime":1792652219,"headline":"Roper Technologies Raises FY2026 Adj EPS Guidance from $22.15-$22.30 to $22.35-$22.40 vs $22.22 Est"}, {"id":143101578,"url":"https://finnhub.io/api/news?id=68cda3b67d8466eb9ba5d420bbb9cc7c2bb2e307ec11bcb2910ba6d48326d752","image":"","source":"Benzinga","related":"ROP","summary":"Roper Techs (NASDAQ:ROP) reported quarterly earnings of $5.89 per share which beat the analyst consensus estimate of $5.79 by 1.73 percent. This is a 14.59 percent increase over earnings of $5.14 per share from the same","category":"company","datetime":1792652136,"headline":"Roper Techs Q3 Adj. EPS $5.89 Beats $5.79 Estimate, Sales $2.172B Inline"}, {"id":143099735,"url":"https://finnhub.io/api/news?id=193a22696077603ac318e840808902ba8db27e0b47fb9a6c04ac36436b33ad52","image":"https://cdn.benzinga.com/files/images/story/2026/10/21/earnings-scheduled-1.jpg?width=2048&height=1536","source":"Benzinga","related":"ROP","summary":"Procter & Gamble headlines Thursday’s reports, with investors weighing resilient consumer demand against cost pressures and softer earnings growth. Union Pacific, Lockheed Martin, Valero Energy and Spotify report","category":"company","datetime":1792596625,"headline":"Procter & Gamble, Western Digital On Deck Thursday As Growth, AI Demand Face Test"}, {"id":143070285,"url":"https://finnhub.io/api/news?id=016b0455c15d0f85fc5d05a9f57bf0d98ee95dc76236e9689f99d0f5b9c8811c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"SCOTTSDALE, Ariz., October 21, 2026--Illumia, a leading provider of identity, commerce, payments, and foodservice technology across higher education, healthcare, and corporate campuses, today announced an expanded partnership with HID, a worldwide leader in trusted identity and access control solutions, that will make it easier and less expensive for colleges and universities to adopt mobile credentials.","category":"company","datetime":1792591200,"headline":"Illumia and HID Strengthen Partnership to Simplify Campus Mobile Credential Adoption"}, {"id":143043383,"url":"https://finnhub.io/api/news?id=2494b4541e8f800fb737c192d434ade1719237be4a79b90562fa553f2b3fe174","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"The updated fair value estimate for Roche Holding is now CHF 383.96, compared with the previous CHF 370.31, which gives investors a fresh anchor for thinking about the stock. Street commentary links this change to a mix of confidence in Roche Holding's base business and ongoing questions around neurology and oncology programs, with both sides using the new figure to test their views. As you read on, you will see how this evolving narrative and the latest trial and deal news can help you track...","category":"company","datetime":1792559882,"headline":"Roche Holding (SWX:ROG) Stock Fair Value Edges Higher After Mixed Analyst Commentary"}, {"id":143030387,"url":"https://finnhub.io/api/news?id=a1e59eef23a0aa4b7bcccb2f66f7213b2f2dd1ebdffdfd8fe76e190647c408c7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding (SWX:ROP) and Genentech plan to present new Phase III lung and breast cancer data at the 2026 ESMO Annual Meeting. The late-stage divarasib results focus on lung cancer, providing fresh evidence on a next-generation targeted therapy approach. Giredestrant Phase III findings in breast cancer are set for a late-breaking session, highlighting updated outcomes in hormone-driven disease. The divarasib and giredestrant Phase III readouts only tell part of the story for Roche's...","category":"company","datetime":1792516446,"headline":"What Could Roche Holding (SWX:ROP) Reveal With New Phase III Cancer Data?"}, {"id":143029148,"url":"https://finnhub.io/api/news?id=e70e95dcf73f456e73c25c2f4eea41fc47e76a3c979fa62aaf19414baba609c6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"ExlService Holdings (EXLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1792501218,"headline":"ExlService Holdings (EXLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"}, {"id":143008733,"url":"https://finnhub.io/api/news?id=3ad2c9986c06ae70af6aa221dffb2a2813d24f8b31148d70ffd25c61aed846db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).","category":"company","datetime":1792422003,"headline":"Roper Technologies (ROP) Upgraded to Buy: Here's Why"}, {"id":143006924,"url":"https://finnhub.io/api/news?id=522dbd76efc78e30b4f30e2cd0fa723137110f98a61c1de35c87c7509a067fbb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"ROP heads into Q3 earnings with projected revenue growth of 7.9% and EPS growth of 12.7%, but rising costs and FX headwinds pose challenges.","category":"company","datetime":1792414560,"headline":"Roper Technologies Set to Report Q3 Earnings: What's in the Cards?"}, {"id":143007033,"url":"https://finnhub.io/api/news?id=4ca72a5eb0b451f7b3d3e056d7245eea8598bdd77b85b11b8953eefa4eabf6ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Besides Wall Street's top-and-bottom-line estimates for Roper Technologies (ROP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.","category":"company","datetime":1792412102,"headline":"What Analyst Projections for Key Metrics Reveal About Roper Technologies (ROP) Q3 Earnings"}, {"id":142987494,"url":"https://finnhub.io/api/news?id=791ca2cf93c7a2d3213304eef5d0a285107390a49ff4c69f39aa9ab8b82530fe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies, Inc. (NASDAQ:ROP) and Danaher Corporation (NYSE:DHR) have returned 4.01% and 18.97%, respectively, over the last six months, as of October 15. This compares to a 21.5% return for the Insider Monkey Billionaire Index and 15.74% for the State Street SPDR S&P 500 ETF Trust. Both have built their businesses around a similar idea: […]","category":"company","datetime":1792334932,"headline":"Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?"}, {"id":142950199,"url":"https://finnhub.io/api/news?id=12b3676a166c2740fb591933a32fd6fd4012c3f77a94363f9b77e7fde56a45e3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding (SWX:ROP) has agreed an exclusive global licence with Rona Therapeutics for an ALK7-targeting RNAi obesity therapy. The licensed RNA interference drug is designed to act in adipose tissue and aims to cut visceral fat while preserving lean mass. The collaboration extends Roche's presence in RNA based treatments for metabolic diseases by using Rona Therapeutics' RNAi platform. Roche's ALK7 RNAi licensing deal with Rona sits alongside other factors that shape the wider picture for...","category":"company","datetime":1792177870,"headline":"Roche Holding (SWX:ROP) Licensed An ALK7 RNAi Obesity Therapy"}, {"id":142950979,"url":"https://finnhub.io/api/news?id=d55d2020ea3d6a37407105110c898f3380c2e49b3449b0a523fc8c044b02dc97","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ROP","summary":"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read full analysis here.","category":"company","datetime":1792173679,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of October 18"}, {"id":142919514,"url":"https://finnhub.io/api/news?id=53bcce5677d8aab51062b6ac673ebe27eb3f2609d3d8ba2d29da98535a3c7c9d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","category":"company","datetime":1792069217,"headline":"Roper Technologies (ROP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"}, {"id":142849083,"url":"https://finnhub.io/api/news?id=029b3d37611e4906fe4a8f12d46ea2ce329ef2457a1ffdefa864473ceb0bcdaf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"PORTLAND, Ore., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Record diesel prices helped push truckload rates higher in September despite lower volumes for dry van and refrigerated (“reefer”) freight compared with August, according to DAT Freight & Analytics. Spot and contract rates including fuel rose for all three equipment types as the monthly national average on-highway diesel price surpassed $6 for the first time. Excluding fuel, van and flatbed rates declined in both markets while reefer rates increa","category":"company","datetime":1791896400,"headline":"DAT: Truckload rates rise in September as diesel tops $6 a gallon"}, {"id":142847536,"url":"https://finnhub.io/api/news?id=0e2b7726efb13a2ddf433a034dba981895318d945e3ee726a42ed471825e4c3a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Customers can now synchronize financial data with Oracle Fusion Cloud ERP through a single, PowerPlan-supported integration, with no custom code to maintainATLANTA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- PowerPlan, a leading provider of financial software solutions for asset-intensive companies, today announced the launch of the PowerPlan Enterprise Adapter for Oracle® Fusion Cloud ERP. The new Adapter gives customers using Oracle Fusion Cloud Enterprise Resource Planning (ERP) a standard, supported","category":"company","datetime":1791889200,"headline":"New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP"}, {"id":142844949,"url":"https://finnhub.io/api/news?id=3c1f5ecd53c64453de203ad527f7c50bbe1a6561bab793158690ffddaf971f92","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Genentech, part of Roche Holding (SWX:ROP), reported new Phase III results for vamikibart in uveitic macular edema (UME). The data suggest vamikibart could become the first non steroid targeted therapy option for this severe cause of vision loss. The FDA has accepted a Biologics License Application for vamikibart in UME, with a decision currently scheduled for 2027. These Phase III vamikibart results and the FDA filing only capture one side of Roche Holding's risk and opportunity mix. Our...","category":"company","datetime":1791886368,"headline":"Roche Holding (SWX:ROP) Reports Phase III Vamikibart Data In Uveitic Macular Edema"}, {"id":142850816,"url":"https://finnhub.io/api/news?id=c9c5379457e9fc91ca539ecf37db2241cc92ccb4bb0aceffe40cf289a30308c7","image":"","source":"Benzinga","related":"ROP","summary":"PowerPlan, a leading provider of financial software solutions for asset-intensive companies, today announced the launch of the PowerPlan Enterprise Adapter for Oracle® Fusion Cloud ERP. The new Adapter gives customers","category":"company","datetime":1791876013,"headline":"Roper Technologies' PowerPlan Announces Launch Of PowerPlan Enterprise Adapter For Oracle Fusion Cloud ERP"}, {"id":142820331,"url":"https://finnhub.io/api/news?id=cac5ad856f098b8e8a5ddf946f61befd473a965d97329cd5deae00076b837cb5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Company to engage school HR leaders through an interactive booth experience and two conference sessionsWayne, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Frontline Education, a leading provider of administration software purpose-built for K–12, will join school personnel leaders at the American Association of School Personnel Administrators (AASPA) 88th Annual Conference, October 12–15 in Austin, Texas. As a Blue Diamond Elite sponsor, Frontline will offer attendees an early look at a new initiative","category":"company","datetime":1791806460,"headline":"Frontline Education to Preview New Vision for K–12 District Operations at AASPA 2026"}, {"id":142765483,"url":"https://finnhub.io/api/news?id=cd7cfc23f582dc1cb8012530fbbb1f30652b8c51e8a5a5d60c5411666ea5ea93","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies (ROP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1791558602,"headline":"Why Roper Technologies (ROP) is Poised to Beat Earnings Estimates Again"}, {"id":142736665,"url":"https://finnhub.io/api/news?id=492d8d540e3e6bd69a4650a106f1fde4ffedbeed8963d341f4dbe89b39c520dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding (SWX:ROP) has been back in focus after Roche Diagnostics shipped two molecular testing instruments to support Ebola response efforts in the Democratic Republic of Congo, tying humanitarian work directly to the diagnostics segment. Against this backdrop, Roche Holding shares trade at CHF352.7 after a 1-day share price return that declined 2.03%. The 90-day share price return of 4.78% and 1-year total shareholder return of 23.81% indicate that momentum has been gradually building...","category":"company","datetime":1791505232,"headline":"Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus"}, {"id":142727762,"url":"https://finnhub.io/api/news?id=6cece6a22102082822d8c1f28fcb1e5be4656fb183d40a70c029c43b6b66a832","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies recently appointed Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., to its Board of Directors for a term running through the 2027 Annual Meeting of Stockholders, adding deep cloud and artificial intelligence expertise to its governance bench. Alongside this board refresh, Roper signaled a stronger focus on internal value creation by expanding its share repurchase activity and lifting revenue guidance, underpinned by recurring software revenue...","category":"company","datetime":1791462058,"headline":"What Roper Technologies (ROP)'s AI-Focused Board Addition and Bigger Buybacks Strategy Shift Means For Shareholders"}, {"id":142720356,"url":"https://finnhub.io/api/news?id=d998a1d2f0f723a5a60cf2c6163b3956d4448bf3f113706b7a80657332b936a2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding has delivered a strong multi year share price run, and with the stock last closing at CHF 360.00 the live question is whether that price still lines up with what its earnings support. Recent product milestones and licensing deals keep reshaping the story, so the issue for you is how much of that is already reflected in the earnings multiple today. Roche Holding has returned 57.1% over the past 3 years, which puts real weight on the question of whether its current P/E is...","category":"company","datetime":1791450486,"headline":"Roche (SWX:ROP) Stock Looks Undervalued Despite Recent Pipeline Progress"}, {"id":142701613,"url":"https://finnhub.io/api/news?id=a47d71db1f0a6775cdb0740f145a80fabd4c3719062ccc0f451d55c05c88e6bf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies has had a rough stretch on the market, which raises a straightforward question for you as an investor: Is the current share price still in line with what the company’s cash flows can justify? The stock is down 30.4% over the past year, which puts the focus squarely on whether that drop now better reflects the value of its underlying cash generation. Management has leaned into share repurchases and higher earnings expectations, a shift that can change how much future cash...","category":"company","datetime":1791415032,"headline":"Is Roper Technologies (ROP) Trading At A Discount To Cash Flow?"}, {"id":142698583,"url":"https://finnhub.io/api/news?id=4e74f41ad7cb5841048a4293c13cf3c7a6465a72160f03630f32f7776987642c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Board shake-up puts fresh AI expertise on Roper Technologies under investor focus Roper Technologies (ROP) has drawn fresh attention after appointing Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, to its Board of Directors effective October 1, 2026. The move arrives as investors already watching Roper Technologies for its compressed valuation and cash generation now consider how Dubey’s enterprise AI background could inform the company’s software heavy portfolio and...","category":"company","datetime":1791389584,"headline":"Roper Technologies (ROP) Adds AI Expertise On The Board As Fair Value Debate Builds"}, {"id":142697442,"url":"https://finnhub.io/api/news?id=717ed62f63e22f9d7b853fba55d72decb4b0ce6cbc90fa3b0af1de52f763a2e1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies, Inc. (NASDAQ:ROP) spent $3.2 billion repurchasing shares over three quarters as software acquisition opportunities became harder to justify. Specialized workflows create switching costs, but artificial intelligence is increasing development demands across software. Buying more of an established business can improve shareholder returns, provided financing costs do not consume the benefit. Roper Technologies, Inc. […]","category":"company","datetime":1791382901,"headline":"Roper (ROP): Are Buybacks a Better Use of Cash than More Acquisitions?"}, {"id":142677662,"url":"https://finnhub.io/api/news?id=5a1080cc60c6e4d70904e7f1730b619d75d1122d823cbda320bb3ba656262ed4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic public-private partnerships are powering rapid testing and a more effective disease response. As a result, Roche Diagnostics has committed to reinforcing local laboratory testing capacity and training laboratory staff to boost essential testing capacity.1","category":"company","datetime":1791349200,"headline":"Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC"}, {"id":142639924,"url":"https://finnhub.io/api/news?id=c7bf6859dde4b6b60fa00382260f27a7b2340fecd2d976dba66075a4fca97db7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies, Inc. (NASDAQ:ROP) does not fit the usual image of a technology company. There is no race to win over the biggest consumer audience or become the next major tech platform. Roper has taken a quieter route. The company owns businesses that sell specialized software and technology to industries such as healthcare, insurance, education, […]","category":"company","datetime":1791238911,"headline":"Roper Technologies Looks More Attractive after its Valuation Compression"}, {"id":142662618,"url":"https://finnhub.io/api/news?id=d78ffd39021735e4739cfbbd4e7ce2c89bcdbad94ff4f003fc44637d8d221831","image":"https://cdn.benzinga.com/files/images/story/2026/10/05/Nasdaq-Inscription-Next-To-Us-Dollars--T.jpg?width=2048&height=1536","source":"Benzinga","related":"ROP","summary":"The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.","category":"company","datetime":1791212429,"headline":"Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average"}, {"id":142613711,"url":"https://finnhub.io/api/news?id=91cd8d60fc00c2577fdfc6780ff23d8333aea25464e586343cd97c08e410bd44","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Bond markets are throwing out fresh stress signals, with investors racing toward German Bunds and dumping riskier debt across Europe. That kind of flight to safety can punish cyclical stocks and fragile balance sheets, yet it can also shine a harsh but helpful spotlight on sturdier businesses. This article explores 3 Core European Defensive Equities that are closely exposed to this bond shock and explains why their reactions might matter for your portfolio decisions now. The three stocks...","category":"company","datetime":1791033000,"headline":"3 European Defensive Stocks Investors Are Watching As Bond Markets Turn Risk Off"}, {"id":142563037,"url":"https://finnhub.io/api/news?id=c3e29ab68e13cd190e6b4f7cd07c0a34261ef20dff247ef7e6ef9675201b621c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding (SWX:ROP) received FDA acceptance of its New Drug Application for fenebrutinib in multiple sclerosis under priority review. The filing covers fenebrutinib as an oral BTK inhibitor for both relapsing and primary progressive forms of multiple sclerosis. If approved, fenebrutinib could become the first high efficacy oral BTK inhibitor targeting both relapse control and disability progression in MS. The FDA's priority review for fenebrutinib in relapsing and primary progressive MS...","category":"company","datetime":1790885291,"headline":"What Could Roche Holding (SWX:ROP) Gain From FDA Priority Review In MS?"}, {"id":142563036,"url":"https://finnhub.io/api/news?id=4f2eb937cf93a144574fcaeb586131c1c604cb69e0bed81403e896e6e8a65f8b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roper Technologies is expected to release its third-quarter earnings soon, and analysts expect a double-digit percentage rise in its bottom line.","category":"company","datetime":1790864390,"headline":"Roper Technologies' Q3 2026 Earnings: What to Expect"}, {"id":142558009,"url":"https://finnhub.io/api/news?id=9442475477b2bca52522c378719c3231cb8ff1f8480065ee740907f1356ab997","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that Abhijit Dubey has joined the Company's Board of Directors. Mr. Dubey is Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., a global business and technology services company. He also serves as a Director of NTT DATA Group Corporation, the publicly listed parent company of NTT DATA, Inc. In his current role, Mr. Dubey leads NTT DATA's strategy, growth, and operating performance, as","category":"company","datetime":1790857980,"headline":"Abhijit Dubey joins Roper Technologies Board of Directors"}, {"id":142558010,"url":"https://finnhub.io/api/news?id=9cb466dcc0f590782c5bde06b7328d7ad59b42c543c212b41b1a293d899d85f3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the third quarter of 2026, ended September 30, 2026, will be released before the market opens on Thursday, October 22, 2026. A conference call to discuss these results has been scheduled for 8:00 AM ET on Thursday, October 22, 2026. The call can be accessed via webcast or by dialing +1 800-836-8184 (US/Canada) or +1 646-357-8785, using conference call ID 80101. Webcas","category":"company","datetime":1790857800,"headline":"Roper Technologies schedules third quarter 2026 financial results conference call"}, {"id":141319340,"url":"https://finnhub.io/api/news?id=2da6ec745278e3a811925654f9b41382ae6d2f8b5083263bfc7c9581a7b3287d","image":"","source":"Benzinga","related":"ROP","summary":"","category":"company","datetime":1790851858,"headline":"Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotation"}, {"id":142511641,"url":"https://finnhub.io/api/news?id=efa6f4188a13eb99717318fd9d826948311cf88b2b110451afb0ad488a81a0f8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark. The test simultaneously screens for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD). This launch provides a crucial, ready-to-use solution for private and academic hospital labs, enabling the ea","category":"company","datetime":1790744400,"headline":"Roche launches newborn screening test for three severe genetic conditions"}, {"id":142498404,"url":"https://finnhub.io/api/news?id=8bc4329cf36853fce5b9df1678eebb50dcd6557db4d207f5557abca810180a7f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"CTSH vs. ROP: Which Stock Is the Better Value Option?","category":"company","datetime":1790692805,"headline":"CTSH or ROP: Which Is the Better Value Stock Right Now?"}, {"id":142453159,"url":"https://finnhub.io/api/news?id=a858de7c4755f727def1d938c4a395431e61d53c9193adecc8cfe68e25951e21","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260312486/image_2260312486.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"ROP","summary":"The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.","category":"company","datetime":1790556963,"headline":"Best Dividend Aristocrats For October 2026"}, {"id":142450095,"url":"https://finnhub.io/api/news?id=6fd169426761dcd79b66169b362e590d15428249512278254ccd229399b1e755","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"Roche Holding (SWX:ROP) announced new R&D alliances focused on AI-powered therapeutics and metabolic disease programs in late September 2026. The group signed a research partnership with Earendil Labs to apply AI to bispecific antibody cancer therapies across multiple tumor types. Roche agreed a collaboration with Atavistik Bio to pursue allosteric small molecules for cardiovascular, renal and metabolic conditions. Enicepatide (CT-388) reported positive Phase 2 results in type 2 diabetes and...","category":"company","datetime":1790539594,"headline":"Roche Holding (SWX:ROP) Signed New AI Drug Discovery Partnerships"}, {"id":142447392,"url":"https://finnhub.io/api/news?id=c0871dd852f73a37e67bb351298164d5068e8c1a8a65b3973ad167d444c0e5d1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"ROP","summary":"A fat dividend yield can signal generosity or a countdown clock, and retirees who chase the wrong one lose twice when the payout finally breaks. Four tests separate the durable payers from the traps before the cut arrives.","category":"company","datetime":1790517649,"headline":"4 Dividend Rules That Keep Retirees From Buying a Payout That Gets Cut"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 6
recomputed_at_score true
sentiment_score_raw 1.8
source_article_count 72
discarded_article_count 45
sentimentPoints 8

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 4.6 5/110 92% 4.6
資金流 13.2 20/110 66% 13.2
市場環境 7.4 15/110 49.33% 7.4
催化劑 10 20/110 50% 10
風險管理 6.8 10/110 68% 6.8
技術信號 17 30/110 56.67% 17
情緒分析 8 10/110 80% 8

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 17/50
ret_5d 0.0911
max_score 50
max_total 50
raw_total 17
vcp_bonus 0
vol_ratio 1.415
ret_points 12
vol_points 4
range_ratio 0.8378
volat_points 0
day_range_pct 0.021
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.7519
turnoverUsdM 508.1487
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.ROP
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 410.5672

strength_details

ma_score 1
atr_score 2
rsi_score 0.5
macd_score 3
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.5
take_profit_price 460.9834
target_multiplier 1.9
technical_strength 1.75
take_profit_percent 6.1
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Information Technology
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.5038
diversificationPoints 2

Calculation audit log

基本面分析總分: 4.6/5分
資金流分析總分: 13.2/20分
市場環境分析總分: 7.4/15分
催化劑分析: 10/20分
風險管理總分: 6.8/10分
技術信號分析總分: 17/30分
情緒分析: 8/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 100
atr
atr 11.9564
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.75
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value 145.46
cmf
rule Cursor_18.24 CMF bands
level 輕微流入
score 6
value 0.1703
kdj
d 88.36
j 82.5
k 86.41
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 84.79
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value -576656
recentSlope 549594.4
previousSlope 232640
rsi
value 91.33
sar
rule Cursor_18.24 Parabolic SAR
score 8
trend 上升
value 413.8701
position SAR喺價下
distancePct 4.74
previousTrend 上升
ma50
value 389.4396
macd
macd 14.8251
trend 強烈看漲
signal 6.0279
histogram 8.7972
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 392.1586
position 連續5日>VWAP
consecutiveAbove 12
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.37
score 6
avgVolume 854563
currentVolume 1169556
derived
ma20 384.111
ma50 389.4396
prevClose 441.65
avgVolume10 1022266
avgVolume20 854563
changePercent -1.62
avgVolumeForScore 854563
ma_cross
ma20 384.111
ma50 389.4396
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 379.8595
prevMa50 388.5442
spreadPct 1.37
isVolumeBreakout false
bollinger
lower 325.0575
upper 443.1645
position 上半部
rsi_short
value 88.26
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.37

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.7518872502327554,
        "turnoverUsdM": 508.14870257556,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.ROP",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 410.5672,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5.5,
      "take_profit_price": 460.9834,
      "target_multiplier": 1.9,
      "technical_strength": 1.75,
      "take_profit_percent": 6.1
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Information Technology",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.503774500465511,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 84,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 67,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 17
  },
  "market": {
    "ma20": 384.111,
    "ma50": 389.4396,
    "close": 434.48,
    "prevClose": 441.65,
    "avgVolume20": 854563,
    "volumeRatio": 1.37,
    "changePercent": -1.62
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 17,
    "details": {
      "ret_5d": 0.09108264712294134,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 17,
      "vcp_bonus": 0,
      "vol_ratio": 1.4149937389978766,
      "ret_points": 12,
      "vol_points": 4,
      "range_ratio": 0.8378358627197887,
      "volat_points": 0,
      "day_range_pct": 0.020967569946428566,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 84,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 92,
        "contribution": 4.6
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 7.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 49.33,
        "contribution": 7.4
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 17,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 56.67,
        "contribution": 17
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "謹慎買入",
    "result": 67,
    "details": [
      "基本面分析總分: 4.6/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 7.4/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 17/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 4.6,
      "資金流": 13.2,
      "市場環境": 7.4,
      "情緒分析": 8,
      "技術信號": 17,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.5,
          "marginPoints": 0.75,
          "turnoverUsdM": 508.14870257556,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ROP",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.39
            }
          },
          "trend": {
            "score": 1.7999999999999998,
            "details": {
              "qqq": {
                "ma20": 733.18400235,
                "ma50": 725.2621992000002,
                "name": "QQQ",
                "close": 721.23999,
                "points": 0.4
              },
              "spy": {
                "ma20": 770.4114959000001,
                "ma50": 767.5287948999999,
                "name": "SPY",
                "close": 769.65997,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.7518872502327554,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 1.8,
          "marketTrendPoints": 1.7999999999999998
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 6,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143234657,
                "url": "https://finnhub.io/api/news?id=abb42726f9194b1f9f2d877aae1d467b8dcc4fd922276c49e688d2c56c93e5bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies reported third quarter 2026 sales of US$2,171.8 million and net income of US$484.7 million, with GAAP diluted EPS from continuing operations of US$4.88. The company also issued fourth quarter GAAP DEPS guidance of US$4.27 to US$4.32, plus full year guidance of US$25.60 to US$25.65. The nine month numbers, including US$6,376 million in sales and US$2,162.1 million in net income, highlight how Roper Technologies’ software heavy portfolio is currently converting revenue into...",
                "category": "company",
                "datetime": 1793106727,
                "headline": "Did Earnings Beat Just Shift Roper Technologies (ROP) Investment Narrative?"
              },
              {
                "id": 143234658,
                "url": "https://finnhub.io/api/news?id=675afc98361468a388b4330cef5f25647af91cbe677acd3cb0ab3112ae4b5e8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) is back in focus after releasing third quarter results showing higher sales, earnings and per share profits, alongside fresh guidance for the fourth quarter and full year 2026. That earnings beat has coincided with a sharp shift in sentiment, with a 7 day share price return of 15.16% and a 30 day gain of 23.17% pushing Roper Technologies to US$441.65, even though the 1 year total shareholder return is still down 3.84%. Scan how Roper Technologies compares with other...",
                "category": "company",
                "datetime": 1793102907,
                "headline": "Roper Technologies (ROP), What Is Behind The Fresh Attention?"
              },
              {
                "id": 143166055,
                "url": "https://finnhub.io/api/news?id=e62f46f508d0e89dd36db60a4043b87d3ac6d3ded9befe7c05a37d3780ebd303",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding has delivered a strong multi year share price run, helped by a busy drug pipeline and fresh clinical data. This raises a simple question for you as an investor: Is the current price still aligned with what the business is earning today? Roche Holding has returned 82.3% over the past 3 years, so a lot of optimism about its earnings power is already reflected in the recent share price story. Recent Phase III results in kidney disease and neuroimmunology, plus new collaborations...",
                "category": "company",
                "datetime": 1792858454,
                "headline": "Can Roche Holding (SWX:ROP) Still Be Cheap After Fresh Trial Wins?"
              },
              {
                "id": 143104800,
                "url": "https://finnhub.io/api/news?id=eda56412a9bf8d111997cd779adb0d407aebce2dee25e1bb764c3fb6eabb95fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies has rallied sharply in recent weeks, which puts the focus squarely on whether the current share price lines up with what its cash flows can justify. For anyone following the stock, the question now is whether that move is supported by the cash the business is expected to generate over time. The share price has risen 19.9% over the past month, which puts more pressure on the underlying cash flow story to support where Roper Technologies now trades. The company focuses on...",
                "category": "company",
                "datetime": 1792710836,
                "headline": "Roper (ROP) Stock May Be 16% Undervalued On Cash Flow"
              },
              {
                "id": 143103823,
                "url": "https://finnhub.io/api/news?id=cc16cb08ed07a3a289e24d2ec61d1809b17b4f4833e9552bed971180b3eb57f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Software momentum drove 7% organic growth as management raised full-year guidance.",
                "category": "company",
                "datetime": 1792692924,
                "headline": "Roper (ROP) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143102762,
                "url": "https://finnhub.io/api/news?id=35d58b3c4add634369f4b436981903e24a70bf74d8b124c91a90d11a48f3b417",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper beats Q3 earnings estimates as 7% organic revenue growth fueled all three segments, while higher 2026 earnings guidance signals continued growth.",
                "category": "company",
                "datetime": 1792680600,
                "headline": "ROP Q3 Earnings Beat Estimates on Solid Organic Growth"
              },
              {
                "id": 143100654,
                "url": "https://finnhub.io/api/news?id=21cf17c3e8c277fa4d7ebee36e513c17ab551274b4c01f76f786328ea2ad8142",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Although the revenue and EPS for Roper Technologies (ROP) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1792672204,
                "headline": "Roper Technologies (ROP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates"
              },
              {
                "id": 143099600,
                "url": "https://finnhub.io/api/news?id=c44273d4b70d1a497a094cfc237b2a1dc4ed7eb3492d21a490236ed01e8fb1ec",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "Roper Q3 2026 results met estimates; FY adjusted EPS guidance raised. Shares slipped premarket after a strong run. Read key earnings takeaways.",
                "category": "company",
                "datetime": 1792672067,
                "headline": "Roper Technologies (NASDAQ:ROP) Q3 2026: In-Line Results and Raised EPS Guidance Meet a Muted Market Reaction"
              }
            ],
            "raw_source": [
              {
                "id": 143234657,
                "url": "https://finnhub.io/api/news?id=abb42726f9194b1f9f2d877aae1d467b8dcc4fd922276c49e688d2c56c93e5bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies reported third quarter 2026 sales of US$2,171.8 million and net income of US$484.7 million, with GAAP diluted EPS from continuing operations of US$4.88. The company also issued fourth quarter GAAP DEPS guidance of US$4.27 to US$4.32, plus full year guidance of US$25.60 to US$25.65. The nine month numbers, including US$6,376 million in sales and US$2,162.1 million in net income, highlight how Roper Technologies’ software heavy portfolio is currently converting revenue into...",
                "category": "company",
                "datetime": 1793106727,
                "headline": "Did Earnings Beat Just Shift Roper Technologies (ROP) Investment Narrative?"
              },
              {
                "id": 143234658,
                "url": "https://finnhub.io/api/news?id=675afc98361468a388b4330cef5f25647af91cbe677acd3cb0ab3112ae4b5e8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) is back in focus after releasing third quarter results showing higher sales, earnings and per share profits, alongside fresh guidance for the fourth quarter and full year 2026. That earnings beat has coincided with a sharp shift in sentiment, with a 7 day share price return of 15.16% and a 30 day gain of 23.17% pushing Roper Technologies to US$441.65, even though the 1 year total shareholder return is still down 3.84%. Scan how Roper Technologies compares with other...",
                "category": "company",
                "datetime": 1793102907,
                "headline": "Roper Technologies (ROP), What Is Behind The Fresh Attention?"
              },
              {
                "id": 143204260,
                "url": "https://finnhub.io/api/news?id=efbec167be6227a085c19a10ed44b0ab4847c5760aeaef1c3380049b1046d021",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "With $6 billion in deployment capacity and mid-90s software retention, Roper has both the firepower and the moat to compound shareholder returns through disciplined M&A.",
                "category": "company",
                "datetime": 1793050476,
                "headline": "Roper Technologies: 3 Key Takeaways for Long-Term Investors"
              },
              {
                "id": 143204022,
                "url": "https://finnhub.io/api/news?id=7481a76e11433e997e2e804e967bcd278caa6ec86f97abe592f7aa9008e58984",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Intel's manufacturing recovery and AI expansion, Novartis' growth drugs and Itau Unibanco's strategic moves headline today's top analyst reports.",
                "category": "company",
                "datetime": 1793043180,
                "headline": "Top Analyst Reports for Intel, Novartis & Itau Unibanco"
              },
              {
                "id": 143233934,
                "url": "https://finnhub.io/api/news?id=b0e5a997f0730047eb65d04bacb237ab99689c804859e402ea219b707ee38366",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/26/Roper-Technologies--Inc--Logo.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "JPMorgan upgraded Roper to Neutral rating and raised its target citing organic growth, earnings and software M&A outlook.",
                "category": "company",
                "datetime": 1793018686,
                "headline": "Roper Technologies Analyst Turns Bullish After Q3 Print"
              },
              {
                "id": 143233935,
                "url": "https://finnhub.io/api/news?id=605bf03079b3ed06887c1eb633ff58dd475fb7e13a17077dc6c69a2d94d096bf",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "JP Morgan  analyst Chigusa Katoku   upgrades Roper Technologies (NASDAQ:ROP) from Underweight to Neutral and raises the price target from $415 to $490.",
                "category": "company",
                "datetime": 1793016624,
                "headline": "JP Morgan Upgrades Roper Technologies to Neutral, Raises Price Target to $490"
              },
              {
                "id": 143195146,
                "url": "https://finnhub.io/api/news?id=645be5240719f0bfb8637e24ad7ff89962905300a709d133cc8f9a73ef89949a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Pre-Market Stock Futures: Futures are trading higher as we head into a new week that will finish out October, with traders trying to rally stocks after last week’s losing effort. With Halloween on Saturday, this week may be as scary as last week. All major indices closed lower again on Friday after a midday attempt […]",
                "category": "company",
                "datetime": 1793015203,
                "headline": "Here Are Monday’s Top Wall Street Analyst Research Calls: Block, Boise Cascade, Equifax, FirstEnergy, Lockheed Martin, Lumentum Holdings, NetApp, Roper Technologies, Spotify, Technology, and More"
              },
              {
                "id": 143166055,
                "url": "https://finnhub.io/api/news?id=e62f46f508d0e89dd36db60a4043b87d3ac6d3ded9befe7c05a37d3780ebd303",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding has delivered a strong multi year share price run, helped by a busy drug pipeline and fresh clinical data. This raises a simple question for you as an investor: Is the current price still aligned with what the business is earning today? Roche Holding has returned 82.3% over the past 3 years, so a lot of optimism about its earnings power is already reflected in the recent share price story. Recent Phase III results in kidney disease and neuroimmunology, plus new collaborations...",
                "category": "company",
                "datetime": 1792858454,
                "headline": "Can Roche Holding (SWX:ROP) Still Be Cheap After Fresh Trial Wins?"
              },
              {
                "id": 143162853,
                "url": "https://finnhub.io/api/news?id=2db318dc4a25c97d1a7494bbdf5136a328c2c69f069372f18733503ae2f3c653",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/attachment/image/219ce2e9e505d26ba97bb843a7c37b56.png?io=w640",
                "source": "SeekingAlpha",
                "related": "ROP",
                "summary": "Wall Street weekly recap: hotter CPI, rising VIX, tech weakness and big bank earnings.",
                "category": "company",
                "datetime": 1792829457,
                "headline": "Wall Street Breakfast: What Moved Markets This Week"
              },
              {
                "id": 143164433,
                "url": "https://finnhub.io/api/news?id=24a8559c9542550e9f8063b8dadafb8e401f1dd7ebcd7a371148f268f1f49bce",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Jefferies  analyst Brent Thill   maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $500 to $540.",
                "category": "company",
                "datetime": 1792774081,
                "headline": "Jefferies Maintains Buy on Roper Technologies, Raises Price Target to $540"
              },
              {
                "id": 143164434,
                "url": "https://finnhub.io/api/news?id=dc798839962a0a60e4c18126dd268e89a314d806990674924bb29ea58a6c3c5d",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Citigroup  analyst George Kurosawa   maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $450 to $525.",
                "category": "company",
                "datetime": 1792766409,
                "headline": "Citigroup Maintains Buy on Roper Technologies, Raises Price Target to $525"
              },
              {
                "id": 143164435,
                "url": "https://finnhub.io/api/news?id=922aedbb64662747cb082dcca41d5363551297bf558e52fcc7507692df045fb7",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Truist Securities  analyst Terry Tillman   maintains Roper Technologies (NASDAQ:ROP) with a Buy and raises the price target from $475 to $500.",
                "category": "company",
                "datetime": 1792763607,
                "headline": "Truist Securities Maintains Buy on Roper Technologies, Raises Price Target to $500"
              },
              {
                "id": 143164436,
                "url": "https://finnhub.io/api/news?id=5f609b495a88ead61dae1912eeb3bafbc6cc6dc92d5359e9931dd4e20aba04c4",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "RBC Capital  analyst Rishi Jaluria   maintains Roper Technologies (NASDAQ:ROP) with a Sector Perform and raises the price target from $417 to $450.",
                "category": "company",
                "datetime": 1792751177,
                "headline": "RBC Capital Maintains Sector Perform on Roper Technologies, Raises Price Target to $450"
              },
              {
                "id": 143104800,
                "url": "https://finnhub.io/api/news?id=eda56412a9bf8d111997cd779adb0d407aebce2dee25e1bb764c3fb6eabb95fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies has rallied sharply in recent weeks, which puts the focus squarely on whether the current share price lines up with what its cash flows can justify. For anyone following the stock, the question now is whether that move is supported by the cash the business is expected to generate over time. The share price has risen 19.9% over the past month, which puts more pressure on the underlying cash flow story to support where Roper Technologies now trades. The company focuses on...",
                "category": "company",
                "datetime": 1792710836,
                "headline": "Roper (ROP) Stock May Be 16% Undervalued On Cash Flow"
              },
              {
                "id": 143104279,
                "url": "https://finnhub.io/api/news?id=b413e4c8b517e8cfdfb1eb9b6ad2fc45d05f0aae5401f53f574ba0fc6f9671c9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Adjusted earnings rose 15% to $5.89 a share, beating expectations.",
                "category": "company",
                "datetime": 1792700640,
                "headline": "Roper Stock Surges on Earnings Beat. Investors See Promise in Its AI Push."
              },
              {
                "id": 143103966,
                "url": "https://finnhub.io/api/news?id=391c657cf8b8bd35500edd8dd058ed723150150e5d1af02abfbbe21633204915",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "Roper Technologies, Allegion and Lennar led S&P 500 gainers on Oct. 22, 2026, while Moderna, Coherent and Lumentum were among the biggest decliners.",
                "category": "company",
                "datetime": 1792695971,
                "headline": "S&P 500 Top Movers: Gainers and Losers for Oct. 22, 2026"
              },
              {
                "id": 143103823,
                "url": "https://finnhub.io/api/news?id=cc16cb08ed07a3a289e24d2ec61d1809b17b4f4833e9552bed971180b3eb57f4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Software momentum drove 7% organic growth as management raised full-year guidance.",
                "category": "company",
                "datetime": 1792692924,
                "headline": "Roper (ROP) Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143103377,
                "url": "https://finnhub.io/api/news?id=c8afb9bea0bf2ab175008c85cd0d14e631a9cdd56fe6f0e655f0cd26a08d43f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Key TakeawaysRoper Technologies shares jumped 9. 2% today after third-quarter adjusted EPS of $5.",
                "category": "company",
                "datetime": 1792689481,
                "headline": "Roper Technologies Soars 9.2% on Earnings Beat and Guidance Raise: “Exceeded Our Expectations”"
              },
              {
                "id": 143103378,
                "url": "https://finnhub.io/api/news?id=e821dc4a6040d0f8414b092b42533f102884622ae912a2fb5f8cc5af82f77d51",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Moby summary of Roper Technologies, Inc.'s Q3 2026 earnings call",
                "category": "company",
                "datetime": 1792688441,
                "headline": "Roper Technologies, Inc. Q3 2026 Earnings Call Summary"
              },
              {
                "id": 143103959,
                "url": "https://finnhub.io/api/news?id=51f992e7d1a0d25e891ecf23d9ee9e29de2639e286d463e8e3dcaab8e7305397",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "S&P 500 top movers for today's session, led by ALLE, ROP, LEN, NDAQ and BX among gainers, while COHR, LRCX, FLEX, VST and CIEN ranked among losers.",
                "category": "company",
                "datetime": 1792686972,
                "headline": "S&P 500 Top Movers: Gainers and Losers in Today's Session"
              },
              {
                "id": 143102761,
                "url": "https://finnhub.io/api/news?id=13f7ed0b26f1e396c0f9e1912d458db1ab30c3cc43b7b2c2ad1288f5b3e796b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (NASDAQ:ROP) reported third-quarter 2026 results marked by 7% organic revenue growth, 15% adjusted diluted earnings-per-share growth and continued investment in artificial intelligence products and bolt-on acquisitions. Revenue rose 8% year over year to $2.2 billion, while EBITDA",
                "category": "company",
                "datetime": 1792681503,
                "headline": "Roper Technologies Q3 Earnings Call Highlights"
              },
              {
                "id": 143102762,
                "url": "https://finnhub.io/api/news?id=35d58b3c4add634369f4b436981903e24a70bf74d8b124c91a90d11a48f3b417",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper beats Q3 earnings estimates as 7% organic revenue growth fueled all three segments, while higher 2026 earnings guidance signals continued growth.",
                "category": "company",
                "datetime": 1792680600,
                "headline": "ROP Q3 Earnings Beat Estimates on Solid Organic Growth"
              },
              {
                "id": 143103957,
                "url": "https://finnhub.io/api/news?id=b64b1675fefb4698e90c91b13a3bd84b8afa72c0ad07e0b0aa287e90b8342fea",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "S&P 500 gap movers in today's session include ALLE, LMT, CSX, PG and ROP among gap-up leaders, while COHR, FLEX, GEV, LRCX and TER were among gap-down laggards.",
                "category": "company",
                "datetime": 1792679747,
                "headline": "S&P 500 Gap-Up and Gap-Down Movers in Today's Session"
              },
              {
                "id": 143133146,
                "url": "https://finnhub.io/api/news?id=2ed675c0f68b6a82b354a501d37a0d3af1af388703cb3284c683b79d0b8610cf",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/22/Menlo-Park--Ca--Usa--June-7--2026-Meta-H.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Meta's higher AI spending plan drags tech lower as Treasurys rally and the 10-year yield drops below 5%. Gold, silver and Bitcoin fall; oil climbs.",
                "category": "company",
                "datetime": 1792675597,
                "headline": "Meta Tumbles 6% on AI Spending Fears, 10-Year Yield Falls Below 5%: Stock Market Today"
              },
              {
                "id": 143100654,
                "url": "https://finnhub.io/api/news?id=21cf17c3e8c277fa4d7ebee36e513c17ab551274b4c01f76f786328ea2ad8142",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Although the revenue and EPS for Roper Technologies (ROP) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
                "category": "company",
                "datetime": 1792672204,
                "headline": "Roper Technologies (ROP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates"
              },
              {
                "id": 143099600,
                "url": "https://finnhub.io/api/news?id=c44273d4b70d1a497a094cfc237b2a1dc4ed7eb3492d21a490236ed01e8fb1ec",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_16_065e226ebd.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "Roper Q3 2026 results met estimates; FY adjusted EPS guidance raised. Shares slipped premarket after a strong run. Read key earnings takeaways.",
                "category": "company",
                "datetime": 1792672067,
                "headline": "Roper Technologies (NASDAQ:ROP) Q3 2026: In-Line Results and Raised EPS Guidance Meet a Muted Market Reaction"
              },
              {
                "id": 143100655,
                "url": "https://finnhub.io/api/news?id=5089936d9b7b38d8a913211444750305caab80995d7a2cb37bf8d8af171fd77d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) delivered earnings and revenue surprises of +1.73% and -0.26%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1792667702,
                "headline": "Roper Technologies (ROP) Q3 Earnings Beat Estimates"
              },
              {
                "id": 143098876,
                "url": "https://finnhub.io/api/news?id=e6fe629a3c93cefb10cc6c6abdd98585f298047eeb679649d7eb990b4ec6a9e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "(ROP) on Thursday reported third-quarter profit of $484.On a per-share basis, the Sarasota, Florida-based company said it had net income of $4.",
                "category": "company",
                "datetime": 1792667091,
                "headline": "Roper Technologies: Q3 Earnings Snapshot"
              },
              {
                "id": 143097805,
                "url": "https://finnhub.io/api/news?id=2e924393526fcc39fb48f5d7855f01ebb11c3294d9d7ac872e727d7352b93a13",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "ROP",
                "summary": "Roper Technologies fits Caviar Cruise quality screens on growth, EBIT and cash profit, but weak liquidity and low standard ROIC warrant caution.",
                "category": "company",
                "datetime": 1792666838,
                "headline": "Roper Technologies (NASDAQ:ROP): A Quality Investing Candidate With Strong Margins and Balance-Sheet Watch Items"
              },
              {
                "id": 143098877,
                "url": "https://finnhub.io/api/news?id=890d1d9e4cc621903c1ee2615832056f3a692e9ca11e0e521e9a5a5130d26e24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Increases full year DEPS guidanceSARASOTA, Fla., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the third quarter ended September 30, 2026. Third quarter 2026 highlights Revenue increased 8% to $2.17 billion; organic revenue was +7% and acquisition contribution was +1%GAAP net earnings increased 22% to $485 million; adjusted net earnings increased 5% to $586 millionAdjusted EBITDA increased 7% to $864 millionGAAP DEPS increased 33% to $4.8",
                "category": "company",
                "datetime": 1792666500,
                "headline": "Roper Technologies Announces Third Quarter Financial Results"
              },
              {
                "id": 143101575,
                "url": "https://finnhub.io/api/news?id=5f6da5854dad153badbeaf5d051173e4a0e26ceb42976da8803128c37d28d9b9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/22/Stock-market-chart-with-green-candlestic.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Roper Techs (NASDAQ:ROP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide real-time access to earnings",
                "category": "company",
                "datetime": 1792660028,
                "headline": "Roper Techs Q3 2026 Earnings Call Transcript"
              },
              {
                "id": 143101576,
                "url": "https://finnhub.io/api/news?id=84f8df6cfe48b7d0593108cae431fb0482df7df9079a89bcb2707b20e1a6437a",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Roper Technologies (NASDAQ:ROP) is looking for Q4 Adj EPS of $5.95-$6.00 vs $5.91 analyst estimate..",
                "category": "company",
                "datetime": 1792652257,
                "headline": "Roper Technologies Sees Q4 Adj EPS $5.95-$6.00 vs $5.91 Est"
              },
              {
                "id": 143101577,
                "url": "https://finnhub.io/api/news?id=9bc943c9314cae8d74c2dd9caee385bf4e0174c28bd6b51c85b4414bce10267f",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Roper Technologies (NASDAQ:ROP) raises FY2026 Adj EPS guidance from $22.15-$22.30 to $22.35-$22.40 vs $22.22 analyst estimate..",
                "category": "company",
                "datetime": 1792652219,
                "headline": "Roper Technologies Raises FY2026 Adj EPS Guidance from $22.15-$22.30 to $22.35-$22.40 vs $22.22 Est"
              },
              {
                "id": 143101578,
                "url": "https://finnhub.io/api/news?id=68cda3b67d8466eb9ba5d420bbb9cc7c2bb2e307ec11bcb2910ba6d48326d752",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Roper Techs (NASDAQ:ROP) reported quarterly earnings of $5.89 per share which beat the analyst consensus estimate of $5.79 by 1.73 percent. This is a 14.59 percent increase over earnings of $5.14 per share from the same",
                "category": "company",
                "datetime": 1792652136,
                "headline": "Roper Techs Q3 Adj. EPS $5.89 Beats $5.79 Estimate, Sales $2.172B Inline"
              },
              {
                "id": 143099735,
                "url": "https://finnhub.io/api/news?id=193a22696077603ac318e840808902ba8db27e0b47fb9a6c04ac36436b33ad52",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/21/earnings-scheduled-1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "Procter & Gamble headlines Thursday’s reports, with investors weighing resilient consumer demand against cost pressures and softer earnings growth. Union Pacific, Lockheed Martin, Valero Energy and Spotify report",
                "category": "company",
                "datetime": 1792596625,
                "headline": "Procter & Gamble, Western Digital On Deck Thursday As Growth, AI Demand Face Test"
              },
              {
                "id": 143070285,
                "url": "https://finnhub.io/api/news?id=016b0455c15d0f85fc5d05a9f57bf0d98ee95dc76236e9689f99d0f5b9c8811c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "SCOTTSDALE, Ariz., October 21, 2026--Illumia, a leading provider of identity, commerce, payments, and foodservice technology across higher education, healthcare, and corporate campuses, today announced an expanded partnership with HID, a worldwide leader in trusted identity and access control solutions, that will make it easier and less expensive for colleges and universities to adopt mobile credentials.",
                "category": "company",
                "datetime": 1792591200,
                "headline": "Illumia and HID Strengthen Partnership to Simplify Campus Mobile Credential Adoption"
              },
              {
                "id": 143043383,
                "url": "https://finnhub.io/api/news?id=2494b4541e8f800fb737c192d434ade1719237be4a79b90562fa553f2b3fe174",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "The updated fair value estimate for Roche Holding is now CHF 383.96, compared with the previous CHF 370.31, which gives investors a fresh anchor for thinking about the stock. Street commentary links this change to a mix of confidence in Roche Holding's base business and ongoing questions around neurology and oncology programs, with both sides using the new figure to test their views. As you read on, you will see how this evolving narrative and the latest trial and deal news can help you track...",
                "category": "company",
                "datetime": 1792559882,
                "headline": "Roche Holding (SWX:ROG) Stock Fair Value Edges Higher After Mixed Analyst Commentary"
              },
              {
                "id": 143030387,
                "url": "https://finnhub.io/api/news?id=a1e59eef23a0aa4b7bcccb2f66f7213b2f2dd1ebdffdfd8fe76e190647c408c7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding (SWX:ROP) and Genentech plan to present new Phase III lung and breast cancer data at the 2026 ESMO Annual Meeting. The late-stage divarasib results focus on lung cancer, providing fresh evidence on a next-generation targeted therapy approach. Giredestrant Phase III findings in breast cancer are set for a late-breaking session, highlighting updated outcomes in hormone-driven disease. The divarasib and giredestrant Phase III readouts only tell part of the story for Roche's...",
                "category": "company",
                "datetime": 1792516446,
                "headline": "What Could Roche Holding (SWX:ROP) Reveal With New Phase III Cancer Data?"
              },
              {
                "id": 143029148,
                "url": "https://finnhub.io/api/news?id=e70e95dcf73f456e73c25c2f4eea41fc47e76a3c979fa62aaf19414baba609c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "ExlService Holdings (EXLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1792501218,
                "headline": "ExlService Holdings (EXLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 143008733,
                "url": "https://finnhub.io/api/news?id=3ad2c9986c06ae70af6aa221dffb2a2813d24f8b31148d70ffd25c61aed846db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1792422003,
                "headline": "Roper Technologies (ROP) Upgraded to Buy: Here's Why"
              },
              {
                "id": 143006924,
                "url": "https://finnhub.io/api/news?id=522dbd76efc78e30b4f30e2cd0fa723137110f98a61c1de35c87c7509a067fbb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "ROP heads into Q3 earnings with projected revenue growth of 7.9% and EPS growth of 12.7%, but rising costs and FX headwinds pose challenges.",
                "category": "company",
                "datetime": 1792414560,
                "headline": "Roper Technologies Set to Report Q3 Earnings: What's in the Cards?"
              },
              {
                "id": 143007033,
                "url": "https://finnhub.io/api/news?id=4ca72a5eb0b451f7b3d3e056d7245eea8598bdd77b85b11b8953eefa4eabf6ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Besides Wall Street's top-and-bottom-line estimates for Roper Technologies (ROP), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.",
                "category": "company",
                "datetime": 1792412102,
                "headline": "What Analyst Projections for Key Metrics Reveal About Roper Technologies (ROP) Q3 Earnings"
              },
              {
                "id": 142987494,
                "url": "https://finnhub.io/api/news?id=791ca2cf93c7a2d3213304eef5d0a285107390a49ff4c69f39aa9ab8b82530fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies, Inc. (NASDAQ:ROP) and Danaher Corporation (NYSE:DHR) have returned 4.01% and 18.97%, respectively, over the last six months, as of October 15. This compares to a 21.5% return for the Insider Monkey Billionaire Index and 15.74% for the State Street SPDR S&P 500 ETF Trust. Both have built their businesses around a similar idea: […]",
                "category": "company",
                "datetime": 1792334932,
                "headline": "Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?"
              },
              {
                "id": 142950199,
                "url": "https://finnhub.io/api/news?id=12b3676a166c2740fb591933a32fd6fd4012c3f77a94363f9b77e7fde56a45e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding (SWX:ROP) has agreed an exclusive global licence with Rona Therapeutics for an ALK7-targeting RNAi obesity therapy. The licensed RNA interference drug is designed to act in adipose tissue and aims to cut visceral fat while preserving lean mass. The collaboration extends Roche's presence in RNA based treatments for metabolic diseases by using Rona Therapeutics' RNAi platform. Roche's ALK7 RNAi licensing deal with Rona sits alongside other factors that shape the wider picture for...",
                "category": "company",
                "datetime": 1792177870,
                "headline": "Roche Holding (SWX:ROP) Licensed An ALK7 RNAi Obesity Therapy"
              },
              {
                "id": 142950979,
                "url": "https://finnhub.io/api/news?id=d55d2020ea3d6a37407105110c898f3380c2e49b3449b0a523fc8c044b02dc97",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ROP",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read full analysis here.",
                "category": "company",
                "datetime": 1792173679,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of October 18"
              },
              {
                "id": 142919514,
                "url": "https://finnhub.io/api/news?id=53bcce5677d8aab51062b6ac673ebe27eb3f2609d3d8ba2d29da98535a3c7c9d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
                "category": "company",
                "datetime": 1792069217,
                "headline": "Roper Technologies (ROP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release"
              },
              {
                "id": 142849083,
                "url": "https://finnhub.io/api/news?id=029b3d37611e4906fe4a8f12d46ea2ce329ef2457a1ffdefa864473ceb0bcdaf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "PORTLAND, Ore., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Record diesel prices helped push truckload rates higher in September despite lower volumes for dry van and refrigerated (“reefer”) freight compared with August, according to DAT Freight & Analytics. Spot and contract rates including fuel rose for all three equipment types as the monthly national average on-highway diesel price surpassed $6 for the first time. Excluding fuel, van and flatbed rates declined in both markets while reefer rates increa",
                "category": "company",
                "datetime": 1791896400,
                "headline": "DAT: Truckload rates rise in September as diesel tops $6 a gallon"
              },
              {
                "id": 142847536,
                "url": "https://finnhub.io/api/news?id=0e2b7726efb13a2ddf433a034dba981895318d945e3ee726a42ed471825e4c3a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Customers can now synchronize financial data with Oracle Fusion Cloud ERP through a single, PowerPlan-supported integration, with no custom code to maintainATLANTA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- PowerPlan, a leading provider of financial software solutions for asset-intensive companies, today announced the launch of the PowerPlan Enterprise Adapter for Oracle® Fusion Cloud ERP. The new Adapter gives customers using Oracle Fusion Cloud Enterprise Resource Planning (ERP) a standard, supported",
                "category": "company",
                "datetime": 1791889200,
                "headline": "New Enterprise Adapter Offers a Supported PowerPlan Integration Between PowerPlan and Oracle® Fusion Cloud ERP"
              },
              {
                "id": 142844949,
                "url": "https://finnhub.io/api/news?id=3c1f5ecd53c64453de203ad527f7c50bbe1a6561bab793158690ffddaf971f92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Genentech, part of Roche Holding (SWX:ROP), reported new Phase III results for vamikibart in uveitic macular edema (UME). The data suggest vamikibart could become the first non steroid targeted therapy option for this severe cause of vision loss. The FDA has accepted a Biologics License Application for vamikibart in UME, with a decision currently scheduled for 2027. These Phase III vamikibart results and the FDA filing only capture one side of Roche Holding's risk and opportunity mix. Our...",
                "category": "company",
                "datetime": 1791886368,
                "headline": "Roche Holding (SWX:ROP) Reports Phase III Vamikibart Data In Uveitic Macular Edema"
              },
              {
                "id": 142850816,
                "url": "https://finnhub.io/api/news?id=c9c5379457e9fc91ca539ecf37db2241cc92ccb4bb0aceffe40cf289a30308c7",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "PowerPlan, a leading provider of financial software solutions for asset-intensive companies, today announced the launch of the PowerPlan Enterprise Adapter for Oracle® Fusion Cloud ERP. The new Adapter gives customers",
                "category": "company",
                "datetime": 1791876013,
                "headline": "Roper Technologies' PowerPlan Announces Launch Of PowerPlan Enterprise Adapter For Oracle Fusion Cloud ERP"
              },
              {
                "id": 142820331,
                "url": "https://finnhub.io/api/news?id=cac5ad856f098b8e8a5ddf946f61befd473a965d97329cd5deae00076b837cb5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Company to engage school HR leaders through an interactive booth experience and two conference sessionsWayne, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Frontline Education, a leading provider of administration software purpose-built for K–12, will join school personnel leaders at the American Association of School Personnel Administrators (AASPA) 88th Annual Conference, October 12–15 in Austin, Texas. As a Blue Diamond Elite sponsor, Frontline will offer attendees an early look at a new initiative",
                "category": "company",
                "datetime": 1791806460,
                "headline": "Frontline Education to Preview New Vision for K–12 District Operations at AASPA 2026"
              },
              {
                "id": 142765483,
                "url": "https://finnhub.io/api/news?id=cd7cfc23f582dc1cb8012530fbbb1f30652b8c51e8a5a5d60c5411666ea5ea93",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies (ROP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1791558602,
                "headline": "Why Roper Technologies (ROP) is Poised to Beat Earnings Estimates Again"
              },
              {
                "id": 142736665,
                "url": "https://finnhub.io/api/news?id=492d8d540e3e6bd69a4650a106f1fde4ffedbeed8963d341f4dbe89b39c520dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding (SWX:ROP) has been back in focus after Roche Diagnostics shipped two molecular testing instruments to support Ebola response efforts in the Democratic Republic of Congo, tying humanitarian work directly to the diagnostics segment. Against this backdrop, Roche Holding shares trade at CHF352.7 after a 1-day share price return that declined 2.03%. The 90-day share price return of 4.78% and 1-year total shareholder return of 23.81% indicate that momentum has been gradually building...",
                "category": "company",
                "datetime": 1791505232,
                "headline": "Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus"
              },
              {
                "id": 142727762,
                "url": "https://finnhub.io/api/news?id=6cece6a22102082822d8c1f28fcb1e5be4656fb183d40a70c029c43b6b66a832",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies recently appointed Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., to its Board of Directors for a term running through the 2027 Annual Meeting of Stockholders, adding deep cloud and artificial intelligence expertise to its governance bench. Alongside this board refresh, Roper signaled a stronger focus on internal value creation by expanding its share repurchase activity and lifting revenue guidance, underpinned by recurring software revenue...",
                "category": "company",
                "datetime": 1791462058,
                "headline": "What Roper Technologies (ROP)'s AI-Focused Board Addition and Bigger Buybacks Strategy Shift Means For Shareholders"
              },
              {
                "id": 142720356,
                "url": "https://finnhub.io/api/news?id=d998a1d2f0f723a5a60cf2c6163b3956d4448bf3f113706b7a80657332b936a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding has delivered a strong multi year share price run, and with the stock last closing at CHF 360.00 the live question is whether that price still lines up with what its earnings support. Recent product milestones and licensing deals keep reshaping the story, so the issue for you is how much of that is already reflected in the earnings multiple today. Roche Holding has returned 57.1% over the past 3 years, which puts real weight on the question of whether its current P/E is...",
                "category": "company",
                "datetime": 1791450486,
                "headline": "Roche (SWX:ROP) Stock Looks Undervalued Despite Recent Pipeline Progress"
              },
              {
                "id": 142701613,
                "url": "https://finnhub.io/api/news?id=a47d71db1f0a6775cdb0740f145a80fabd4c3719062ccc0f451d55c05c88e6bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies has had a rough stretch on the market, which raises a straightforward question for you as an investor: Is the current share price still in line with what the company’s cash flows can justify? The stock is down 30.4% over the past year, which puts the focus squarely on whether that drop now better reflects the value of its underlying cash generation. Management has leaned into share repurchases and higher earnings expectations, a shift that can change how much future cash...",
                "category": "company",
                "datetime": 1791415032,
                "headline": "Is Roper Technologies (ROP) Trading At A Discount To Cash Flow?"
              },
              {
                "id": 142698583,
                "url": "https://finnhub.io/api/news?id=4e74f41ad7cb5841048a4293c13cf3c7a6465a72160f03630f32f7776987642c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Board shake-up puts fresh AI expertise on Roper Technologies under investor focus Roper Technologies (ROP) has drawn fresh attention after appointing Abhijit Dubey, Chief Executive Officer and Chief AI Officer of NTT DATA, to its Board of Directors effective October 1, 2026. The move arrives as investors already watching Roper Technologies for its compressed valuation and cash generation now consider how Dubey’s enterprise AI background could inform the company’s software heavy portfolio and...",
                "category": "company",
                "datetime": 1791389584,
                "headline": "Roper Technologies (ROP) Adds AI Expertise On The Board As Fair Value Debate Builds"
              },
              {
                "id": 142697442,
                "url": "https://finnhub.io/api/news?id=717ed62f63e22f9d7b853fba55d72decb4b0ce6cbc90fa3b0af1de52f763a2e1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies, Inc. (NASDAQ:ROP) spent $3.2 billion repurchasing shares over three quarters as software acquisition opportunities became harder to justify. Specialized workflows create switching costs, but artificial intelligence is increasing development demands across software. Buying more of an established business can improve shareholder returns, provided financing costs do not consume the benefit. Roper Technologies, Inc. […]",
                "category": "company",
                "datetime": 1791382901,
                "headline": "Roper (ROP): Are Buybacks a Better Use of Cash than More Acquisitions?"
              },
              {
                "id": 142677662,
                "url": "https://finnhub.io/api/news?id=5a1080cc60c6e4d70904e7f1730b619d75d1122d823cbda320bb3ba656262ed4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic public-private partnerships are powering rapid testing and a more effective disease response. As a result, Roche Diagnostics has committed to reinforcing local laboratory testing capacity and training laboratory staff to boost essential testing capacity.1",
                "category": "company",
                "datetime": 1791349200,
                "headline": "Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC"
              },
              {
                "id": 142639924,
                "url": "https://finnhub.io/api/news?id=c7bf6859dde4b6b60fa00382260f27a7b2340fecd2d976dba66075a4fca97db7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies, Inc. (NASDAQ:ROP) does not fit the usual image of a technology company. There is no race to win over the biggest consumer audience or become the next major tech platform. Roper has taken a quieter route. The company owns businesses that sell specialized software and technology to industries such as healthcare, insurance, education, […]",
                "category": "company",
                "datetime": 1791238911,
                "headline": "Roper Technologies Looks More Attractive after its Valuation Compression"
              },
              {
                "id": 142662618,
                "url": "https://finnhub.io/api/news?id=d78ffd39021735e4739cfbbd4e7ce2c89bcdbad94ff4f003fc44637d8d221831",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/05/Nasdaq-Inscription-Next-To-Us-Dollars--T.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQQ has beaten equal-weight QQQE by 8% since late July.",
                "category": "company",
                "datetime": 1791212429,
                "headline": "Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average"
              },
              {
                "id": 142613711,
                "url": "https://finnhub.io/api/news?id=91cd8d60fc00c2577fdfc6780ff23d8333aea25464e586343cd97c08e410bd44",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Bond markets are throwing out fresh stress signals, with investors racing toward German Bunds and dumping riskier debt across Europe. That kind of flight to safety can punish cyclical stocks and fragile balance sheets, yet it can also shine a harsh but helpful spotlight on sturdier businesses. This article explores 3 Core European Defensive Equities that are closely exposed to this bond shock and explains why their reactions might matter for your portfolio decisions now. The three stocks...",
                "category": "company",
                "datetime": 1791033000,
                "headline": "3 European Defensive Stocks Investors Are Watching As Bond Markets Turn Risk Off"
              },
              {
                "id": 142563037,
                "url": "https://finnhub.io/api/news?id=c3e29ab68e13cd190e6b4f7cd07c0a34261ef20dff247ef7e6ef9675201b621c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding (SWX:ROP) received FDA acceptance of its New Drug Application for fenebrutinib in multiple sclerosis under priority review. The filing covers fenebrutinib as an oral BTK inhibitor for both relapsing and primary progressive forms of multiple sclerosis. If approved, fenebrutinib could become the first high efficacy oral BTK inhibitor targeting both relapse control and disability progression in MS. The FDA's priority review for fenebrutinib in relapsing and primary progressive MS...",
                "category": "company",
                "datetime": 1790885291,
                "headline": "What Could Roche Holding (SWX:ROP) Gain From FDA Priority Review In MS?"
              },
              {
                "id": 142563036,
                "url": "https://finnhub.io/api/news?id=4f2eb937cf93a144574fcaeb586131c1c604cb69e0bed81403e896e6e8a65f8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roper Technologies is expected to release its third-quarter earnings soon, and analysts expect a double-digit percentage rise in its bottom line.",
                "category": "company",
                "datetime": 1790864390,
                "headline": "Roper Technologies' Q3 2026 Earnings: What to Expect"
              },
              {
                "id": 142558009,
                "url": "https://finnhub.io/api/news?id=9442475477b2bca52522c378719c3231cb8ff1f8480065ee740907f1356ab997",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that Abhijit Dubey has joined the Company's Board of Directors. Mr. Dubey is Chief Executive Officer and Chief AI Officer of NTT DATA, Inc., a global business and technology services company. He also serves as a Director of NTT DATA Group Corporation, the publicly listed parent company of NTT DATA, Inc. In his current role, Mr. Dubey leads NTT DATA's strategy, growth, and operating performance, as",
                "category": "company",
                "datetime": 1790857980,
                "headline": "Abhijit Dubey joins Roper Technologies Board of Directors"
              },
              {
                "id": 142558010,
                "url": "https://finnhub.io/api/news?id=9cb466dcc0f590782c5bde06b7328d7ad59b42c543c212b41b1a293d899d85f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "SARASOTA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) announced that its financial results for the third quarter of 2026, ended September 30, 2026, will be released before the market opens on Thursday, October 22, 2026. A conference call to discuss these results has been scheduled for 8:00 AM ET on Thursday, October 22, 2026. The call can be accessed via webcast or by dialing +1 800-836-8184 (US/Canada) or +1 646-357-8785, using conference call ID 80101. Webcas",
                "category": "company",
                "datetime": 1790857800,
                "headline": "Roper Technologies schedules third quarter 2026 financial results conference call"
              },
              {
                "id": 141319340,
                "url": "https://finnhub.io/api/news?id=2da6ec745278e3a811925654f9b41382ae6d2f8b5083263bfc7c9581a7b3287d",
                "image": "",
                "source": "Benzinga",
                "related": "ROP",
                "summary": "",
                "category": "company",
                "datetime": 1790851858,
                "headline": "Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO security released for quotation"
              },
              {
                "id": 142511641,
                "url": "https://finnhub.io/api/news?id=efa6f4188a13eb99717318fd9d826948311cf88b2b110451afb0ad488a81a0f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an in vitro diagnostic test for newborn screening in countries accepting the CE mark. The test simultaneously screens for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD). This launch provides a crucial, ready-to-use solution for private and academic hospital labs, enabling the ea",
                "category": "company",
                "datetime": 1790744400,
                "headline": "Roche launches newborn screening test for three severe genetic conditions"
              },
              {
                "id": 142498404,
                "url": "https://finnhub.io/api/news?id=8bc4329cf36853fce5b9df1678eebb50dcd6557db4d207f5557abca810180a7f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "CTSH vs. ROP: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1790692805,
                "headline": "CTSH or ROP: Which Is the Better Value Stock Right Now?"
              },
              {
                "id": 142453159,
                "url": "https://finnhub.io/api/news?id=a858de7c4755f727def1d938c4a395431e61d53c9193adecc8cfe68e25951e21",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2260312486/image_2260312486.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ROP",
                "summary": "The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.",
                "category": "company",
                "datetime": 1790556963,
                "headline": "Best Dividend Aristocrats For October 2026"
              },
              {
                "id": 142450095,
                "url": "https://finnhub.io/api/news?id=6fd169426761dcd79b66169b362e590d15428249512278254ccd229399b1e755",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "Roche Holding (SWX:ROP) announced new R&D alliances focused on AI-powered therapeutics and metabolic disease programs in late September 2026. The group signed a research partnership with Earendil Labs to apply AI to bispecific antibody cancer therapies across multiple tumor types. Roche agreed a collaboration with Atavistik Bio to pursue allosteric small molecules for cardiovascular, renal and metabolic conditions. Enicepatide (CT-388) reported positive Phase 2 results in type 2 diabetes and...",
                "category": "company",
                "datetime": 1790539594,
                "headline": "Roche Holding (SWX:ROP) Signed New AI Drug Discovery Partnerships"
              },
              {
                "id": 142447392,
                "url": "https://finnhub.io/api/news?id=c0871dd852f73a37e67bb351298164d5068e8c1a8a65b3973ad167d444c0e5d1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ROP",
                "summary": "A fat dividend yield can signal generosity or a countdown clock, and retirees who chase the wrong one lose twice when the payout finally breaks. Four tests separate the durable payers from the traps before the cut arrives.",
                "category": "company",
                "datetime": 1790517649,
                "headline": "4 Dividend Rules That Keep Retirees From Buying a Payout That Gets Cut"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 6,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 72,
            "discarded_article_count": 45
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17,
        "grade": "較差",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50;升放量(近10日3日);Ready=N;Confirm=N",
            "vcp_metrics": {
              "up_days": 8,
              "vol_ref": 915730,
              "down_days": 1,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 966590,
              "avg_vol_20": 826545,
              "avg_vol_30": 915730,
              "range_pct_10": 0.19358777864141558,
              "range_pct_20": 0.23777848835899262,
              "range_pct_30": 0.23777848835899262,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0555403885424743,
              "dist_to_20d_high": 0.036116779747165303,
              "down_shrink_days": 1,
              "breakout_level_20d": 450.76001,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.814151776207531
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.7518872502327554,
              "turnoverUsdM": 508.14870257556,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.ROP",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 410.5672,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5.5,
            "take_profit_price": 460.9834,
            "target_multiplier": 1.9,
            "technical_strength": 1.75,
            "take_profit_percent": 6.1
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Information Technology",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.503774500465511,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 11.9564,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.75
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 145.46
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1703
    },
    "kdj": {
      "d": 88.36,
      "j": 82.5,
      "k": 86.41,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 84.79
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": -576656,
      "recentSlope": 549594.4,
      "previousSlope": 232640
    },
    "rsi": 91.33,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 413.8701,
      "position": "SAR喺價下",
      "distancePct": 4.74,
      "previousTrend": "上升"
    },
    "ma50": 389.4396,
    "macd": {
      "macd": 14.825080452497957,
      "trend": "強烈看漲",
      "signal": 6.027852810531469,
      "histogram": 8.797227641966488
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 392.1586,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 12
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.37,
      "score": 6,
      "avgVolume": 854563,
      "currentVolume": 1169556
    },
    "derived": {
      "ma20": 384.111,
      "ma50": 389.4396,
      "prevClose": 441.65,
      "avgVolume10": 1022266,
      "avgVolume20": 854563,
      "changePercent": -1.62,
      "avgVolumeForScore": 854563
    },
    "ma_cross": {
      "ma20": 384.111,
      "ma50": 389.4396,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 379.8595,
      "prevMa50": 388.5442,
      "spreadPct": 1.37,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 325.0575,
      "upper": 443.1645,
      "position": "上半部"
    },
    "rsi_short": 88.26,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.37
    }
  }
}

Raw metrics JSON

{
  "close": 434.48,
  "volume": 1169556,
  "changePercent": -1.62
}

Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.